Juan Figuereo
Analyst · Citi Investment Research
Thank you, Mark. As usual, I'll start with the review of the income statement on a normalized basis. Net sales for the quarter were $1.5 billion, a 2.6% improvement versus the prior year. Core sales, which excludes the impact of foreign currency and product line exits increased 5.7%. Foreign currency had a negative impact of 1.1% on sales during the quarter, and the carryover impact of 2009 product line exits reduced sales by approximately 2%. In North America, net sales were up 2%, driven by increased shelf space and share gains in most of our business units. Core sales increased 4% while product line exits reduced sales 2.6%, and foreign currency had a positive impact of 0.6%. Our International business, led by our APAC region, continued to gain momentum with reported net sales growth of 5% or 11% in local currency. On a year-to-date basis, we reported net sales of $4.3 billion, a 3.2% increase versus the year-ago period while core sales increased 4.6%. We generated gross margin of $567 million or 38.1% of sales, an increase of 70 basis points compared to the third quarter of 2009. The biggest contributors to the improvement were productivity gains resulting from a number of initiatives, including Project Acceleration, higher overhead absorption and favorable product mix driven by product innovation. These positive factors offset significant input cost inflation in the quarter. Year-to-date, we generated gross margin of $1.6 billion or 37.9% of sales, an increase of 130 basis points over the prior year. Although this would appear to be ahead of our guidance, the fact is we are on track to deliver our full year gross margin target improvement of 75 to 100 basis points. I'll provide more details later. SG&A. On a normalized basis, SG&A expenses were $370 million or 24.8% of net sales compared with $350 million or 24.2% of net sales last year. Brand building, which increased about $18 million; and other strategic spending, which increased about $7 million accounted for the majority of the increase, which was partially offset by foreign currency impact of $4 million. Year-to-date, normalized SG&A expenses were $1.1 billion or 24.6% of sales. We anticipate a slightly higher rate of strategic brand building spend in the fourth quarter, aimed at supporting new product launches and seasonal promotions. Operating income on a normalized basis was $198 million or 13.3% of sales. Gross margin expansion during the quarter was partially offset by brand and volume building SG&A expense. On a year-to-date basis, our normalized operating income was $570 million or 13.3% of sales versus 12.8% of sales last year. Interest expense for the quarter and year-to-date was $30.3 million and $95.5 million, respectively, representing a decrease versus the previous year of $5.4 million in the quarter and $11.1 million year-to-date. This improvement was driven by lower average debt levels and a more favorable interest rate environment. During the quarter, we made substantial progress implementing our Capital Optimization Plan, a series of transactions that has given us a simpler, more shareholder-friendly capital structure while also allowing us to take advantage of this historically low interest rate environment. The plan reduces our interest expense and largely eliminates potential future share dilution associated with our convertible notes. There were five key steps in the plan, four of which we completed during the quarter. First, we raised $550 million of straight debt at an attractive 4.7% rate. Next, we used the proceeds from the new debt, along with cash on hand and short-term borrowings, to complete a tender offer for our standing 10.6% notes, which eliminated $279 million principal amount of high-coupon debt. Shortly thereafter, we successfully completed an exchange offer for the convertible notes, taking out $325 million or 94% of the outstanding principal amount, resulting in the issuance of 37.7 million shares. Additionally, we unwound the related call spread we had put in place by settling the underlying warrant and option arrangement, resulting in a net cash inflow of approximately $70 million. The last step in the optimization plan is the accelerated stock buyback of $500 million in outstanding common stock, which started early in August. That's $500 million. We received 25.8 million shares on August 10 and expect to receive an as of yet undetermined amount of additional shares at settlement upon completion of the program. We expect the accelerated stock buyback will be wrapped up by early 2011. Going forward, our expectation is that the interest savings from this plan will more than offset the estimated share count dilution resulting in about $0.03 to $0.05 of EPS accretion in 2011. More importantly, simplifying the capital structure will make it easier for investors to focus on our underlying business and our long-term growth strategy. As it relates to income taxes, our continuing tax rate in the third quarter was 30.5% compared to 31.9% last year. During the quarter, we reversed approximately $63.6 million in tax accruals in connection with the final resolution of a multiyear tax examination and the related release of claims against our company. The favorable impact of this item is not included in the aforementioned normalized continuing tax rate. Our full year continuing tax rate is projected to be between 30% and 31%. Our normalized EPS for the quarter came in at $0.42, an 11% increase over last year. This $0.42 excludes certain positive and negative events that we believe are not indicative of our ongoing results. They relate to the previously mentioned tax settlement, restructuring charges, dilution related to our convertible notes for the portion of the quarter in which they remain outstanding and the impact of our Capital Structure Optimization Plan. Please allow me a few moments to add a little bit more clarity with regards to the more significant normalized items in the quarter. As previously mentioned, the company resolved a multiyear income tax examination during the quarter. The final liability was less than have been reserved, resulting in a $63.6 million or $0.21 per share non-recurring tax benefit. The impact of this benefit has been excluded from our normalized EPS. Normalized EPS also excludes $0.05 per share, reflecting $16 million of Project Acceleration restructuring and related impairment charges and $7 million of restructuring related costs associated with the European Transformation Plan. Restructuring charges included in the prior-year quarter were $27 million or $0.07 per share. Additionally, $0.04 of GAAP dilution is excluded from normalized EPS related to the convertible notes we issued in 2009. This represents the dilution impact for approximately two and a half months. Over 90% of these notes were extinguished during the third quarter of 2010 and therefore, will not have a similar effect in future periods. Please note that due to the call spread feature associated with these notes, the economic dilution would have been only $0.01. In future quarters, the dilution impact from the $20 million stock portion of the notes that remain outstanding is not expected to be material, and as such, will not be excluded from normalized results. As a result of the Capital Structure Optimization Plan transactions, we took a $219 million charge to earnings this quarter, primarily reflecting the repurchase of outstanding debt at greater than book value. This charge has been excluded from normalized results. And lastly, due to the stagger timing of the share repurchase and share issuance pieces of the Capital Structure Optimization Plan transaction, our normalized EPS and diluted average shares outstanding have been adjusted to exclude the impact of the transaction. We look forward to the fourth quarter when we will no longer have the convertible debt noise in our reported numbers. Q4 normalized earnings will not exclude the dilution from the convertible notes nor will it exclude the impact of the Capital Structure Optimization Plan, which together, we believe will be accretive by about $0.01. I know you look forward to that simplification too. Cash flow. We generated $195 million in operating cash flow during Q3, in line with our expectations and a $133 million decrease versus last year's $328 million. The prior-year number reflected a significant reduction in working capital that did not repeat this year. CapEx for the quarter was approximately $39 million versus $37 million last year. During the quarter, we made a $50 million voluntary pension contribution. Now I will turn to our segment information. Home & Family net sales were $609 million, a 2% increase versus last year. Core sales in this segment increased 4%. ForEx [ph] contributed a positive 0.5%, and the impact of last year's product exits reduced sales by 2.5%. Home & Family operating income was $76 million or 12.5% of sales, a decrease of 160 basis points in operating income margin as compared to last year. Most of the decrease was due to the timing of new product launches across the Home & Family portfolio, which as we had previously indicated, was skewed to the back half of the year. Therefore, Q3 SG&A for this segment increased by about $6 million versus last year, driven by the related brand building and strategic spending. As we look forward, we foresee some margin pressure as a result of the increased input cost in this segment. We will look to offset this cost pressure going forward through a combination of productivity and potential pricing actions. In our Office Product segment, Q3 net sales were $450 million, a 0.4% increase versus last year. Core sales grew by 7.5%, primarily attributable to strong results across all of the segments business units, with product line exits reducing sales by 3% and a favorable ForEx of 4.1%. Office Products operating income was $71 million or 15.7% of sales, an increase of 370 basis points in operating margin from a year ago. Most of the increase was driven by better mix and productivity initiatives that expanded gross margins. Total SG&A for this segment was essentially flat versus the year-ago quarter. Brand building and strategic SG&A spend across the segment increased approximately $26 million, while structural SG&A spend decreased as a result of Project Acceleration. Tools, Hardware & Commercial products. In this segment, net sales were $428 million, a 6% increase over last year, driven by core sales growth across all GBUs. Total core growth for the segment was also 6%, as ForEx had a negligible impact in the quarter. International growth, as Mark said earlier, has been the primary driver of growth in this segment, with significant gains of over 16% excluding currency. Double-digit growth was realized in all regions, again, excluding currency. EMEA was up 15%, Latin America, 18%, APAC, 19%. Operating income was $71 million or 16.5% of sales, a decrease of 210 basis points in operating margin from a year ago. The decrease was mainly driven by higher SG&A. Total SG&A for this segment increased $13.7 million. Brand building and strategic SG&A spend across the segment increased approximately $10 million. Now for the 2010 outlook. As Mark indicated earlier, on the strength of our year-to-date performance and on our continued confidence for the fourth quarter, we are confirming our outlook for full year core sales growth of mid-single digits. We still anticipate a 1% to 2% decline from the impact of last year's product line exits and a modestly negative impact from ForEx. Our guidance for full year gross margin expansion of 75 to 100 basis points remains unchanged, although we now expect to be closer to the top end of that range. In the fourth quarter, we expect gross margins to be impacted by the timing of productivity projects, lower overhead absorption due to planned and seasonal reductions in inventory levels and more aggressive disposal of exits and obsolete inventory. As a result, Q4 gross margin expansion will be significantly less than the year-to-date trend. Again, we are on track to deliver the high side of our gross margin expansion guidance for the full year. SG&A spend for the full year is still expected to be at or around 25% of net sales on a normalized basis. Interest expense for the year is expected to come in around $120 million, a decline of approximately 15% compared to 2009, reflecting lower debt levels and lower interest rates for the remainder of the year. As stated earlier, our effective tax rate for the year is projected to be between 30% and 31%. We are re-affirming our outlook for normalized EPS of between $1.40 to $1.50 per share. Again Mark already said it, I'll repeat it, we currently think we will be closer to the high end of that range. We anticipate 2010 pretax restructuring and related charges of between $75 million to $95 million or $0.20 to $0.30 per share associated with Project Acceleration and the European Transformation Plan. Our normalized EPS outlook of $1.40 to $1.50 excludes these charges. We are maintaining our expectations for 2010 operating cash flow of more than $500 million. After $70 million to $100 million in restructuring cash payments, capital expenditures are expected to total between $160 million and $170 million, resulting in free cash flow well in excess of $300 million. In conclusion, we continue to be encouraged by the evidence we're seeing in the marketplace that our strategy is working with customers and consumers. We continue to gain share, increase shelf space, and gain new customers. While we anticipate some continuing headwinds from the slow pace of recovery in North America and Europe, our businesses are gaining momentum, and we are investing behind that momentum. We're feeling confident about our ability to meet our 2010 target and create value for our shareholders. With that, I'll turn the call back over to Mark for his final comments. Mark?